Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

American Bio Medica takes new drug tests to the US:

This article was originally published in Clinica

Executive Summary

American Bio Medica has received US FDA 510(k) clearance for new tests in its Rapid Tec drug testing product series that include assays for methamphetamines and opiates at a 300ng cutoff level. The company has also launched Rapid Tec 5, which tests for THC, cocaine, amphetamines, benzodiazepines, and opiates (300ng), for forensic use. The Kinderhook, New York firm's Rapid Tec products test for drugs-of-abuse in urine and can detect more than one class of drug on a single drug testing strip.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT062489

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel